Syndax Pharmaceuticals (SNDX) Prepaid Assets (2015 - 2026)
Syndax Pharmaceuticals' (SNDX) quarterly Prepaid Assets came in at $980000.0 in Q1 2026, up 2700.0% year-on-year from $35000.0 in Q1 2025, and up 1681.82% quarter-over-quarter from $55000.0 in Q4 2025.
Syndax Pharmaceuticals (SNDX) Prepaid Assets (2015 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Prepaid Assets history runs 12 years deep, the most recent figure standing at $980000.0 for Q1 2026.
- On a quarterly basis, Prepaid Assets rose 2700.0% year-over-year to $980000.0 in Q1 2026; TTM through Mar 2026 was $980000.0, a 2700.0% increase from a year earlier, with the FY2025 full-year figure at $55000.0, down 91.01% from the prior year.
- Prepaid Assets rose to $980000.0 in Q1 2026 per SNDX's latest filing, from $55000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $9.5 million in Q3 2025 and bottomed at $18000.0 in Q2 2025.
- The 5-year median for Prepaid Assets is $1.6 million (2022), against an average of $2.0 million.
- Across the five-year window, Prepaid Assets slumped 99.57% in 2025 and surged 2700.0% in 2026, its largest moves.
- Year by year, Prepaid Assets stood at $1.9 million in 2022, then surged by 71.96% to $3.3 million in 2023, then sank by 81.42% to $612000.0 in 2024, then plunged by 91.01% to $55000.0 in 2025, then jumped by 1681.82% to $980000.0 in 2026.
- Per Business Quant, the three latest SNDX Prepaid Assets figures stand at $980000.0 (Q1 2026), $55000.0 (Q4 2025), and $9.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Syndax Pharmaceuticals | 1.87 Bn | 1.52 Bn | 53.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 980,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 9.52 Mn |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Sep 30, 2024 | 3.51 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 1.82 Mn |
| Dec 31, 2023 | 3.29 Mn |
| Sep 30, 2023 | 1.34 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 152,000.00 |
| Jun 30, 2022 | 1.56 Mn |
| Mar 31, 2022 | 2.15 Mn |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 238,000.00 |
| Jun 30, 2021 | 1.53 Mn |